Global Arterial Blood Gas Kits Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

 Global Arterial Blood Gas Kits Market Size

• The global arterial blood gas kits market was valued at USD 542.63 million in 2024 and is expected to reach USD 987.01 million by 2032
• During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.30%, primarily driven by the increasing global ICU admissions
• This growth is driven by factors such as the aging population, imbalances in blood oxygen level and critical role of ABG analysis in patient management

Global Arterial Blood Gas Kits Market Analysis

• Arterial blood gas (ABG) kits are essential diagnostic tools used in the measurement of blood oxygen (O₂), carbon dioxide (CO₂), and pH levels, providing critical insights into a patient’s respiratory and metabolic status. These kits are widely utilized in intensive care units, emergency rooms, operating theaters, and diagnostic laboratories to manage acute and chronic health conditions such as chronic obstructive pulmonary disease (COPD), asthma, kidney disorders, and sepsis
• The growing prevalence of respiratory and metabolic disorders is the primary factor driving global demand. With increasing rates of hospitalization due to respiratory complications and a rapidly aging population, the need for real-time and accurate blood gas analysis is higher than ever. In addition, technological advancements—such as pre-set plunger modes for enhanced usability, vented syringes for improved safety, and integration with point-of-care testing platforms—are contributing to broader adoption across both developed and emerging economies
• North America remains one of the dominant markets for ABG kits, supported by its well-established healthcare infrastructure, rising ICU admissions, and strong focus on early and accurate diagnosis. For instance, the U.S. sees a high frequency of ABG testing in critical care settings, and ongoing investments in hospital modernization and respiratory care continue to propel market growth
• Globally, ABG kits have become a fundamental component of critical care diagnostics, second only to core point-of-care devices such as pulse oximeters and ECG monitors. Their ability to provide fast, actionable insights into patient respiratory and acid-base status makes them indispensable in life-saving procedures and ongoing patient management

Report Scope and Global Arterial Blood Gas Kits Market Segmentation       

Global Arterial Blood Gas Kits Market Trends

“Increasing Adoption of Digital Integration and Smart Connectivity in ABG Testing”

• One prominent trend in the global arterial blood gas kits market is the growing adoption of digital integration and smart connectivity in blood gas analyzers and syringe systems. These advancements are transforming traditional ABG testing by improving the speed, accuracy, and reliability of diagnostics, particularly in critical care settings 
  • For instance, digitally integrated ABG analyzers now offer automated calibration, real-time data transfer to electronic health records (EHRs), and wireless connectivity, enabling faster clinical decisions and better patient monitoring. This is especially crucial in intensive care units (ICUs), where rapid interpretation of blood gas values can be life-saving 
• Moreover, smart syringe systems with pre-set plunger modes and barcoding functionality enhance traceability and reduce manual errors, contributing to safer sample handling and more efficient workflow. As hospitals and diagnostic labs increasingly adopt connected health technologies, the demand for digitally enabled ABG solutions continues to rise
• This trend is reshaping critical diagnostics by promoting automation, interoperability, and data-driven decision-making, ultimately improving patient outcomes and expanding the market for technologically advanced ABG kits worldwide

Global Arterial Blood Gas Kits Market Dynamics

Driver

“Rising Prevalence of Respiratory and Metabolic Disorders”

• The increasing incidence of respiratory illnesses such as chronic obstructive pulmonary disease (COPD), asthma, acute respiratory distress syndrome (ARDS), and sepsis is significantly driving the demand for arterial blood gas kits
• In addition, the global burden of metabolic disorders such as diabetic ketoacidosis and renal failure, which require regular monitoring of blood gases, pH, and electrolytes, is contributing to consistent market growth
• Aging populations, particularly in regions such as Europe and Asia-Pacific, are more prone to chronic illnesses, leading to greater ICU admissions and increased need for point-of-care blood gas analysis
• Technological advancements in ABG kits, including pre-filled syringes, safety-engineered needles, and automated analysers, are also enhancing clinical workflow and diagnostic accuracy

For instance,

• In June 2023, the Global Burden of Disease Study reported a steady rise in the number of people diagnosed with COPD, making it one of the leading causes of morbidity worldwide—underlining the critical role of ABG testing in patient monitoring
• According to a 2024 WHO report, global ICU admissions have surged post-pandemic, with ABG testing identified as a standard of care in over 90% of critical care protocols 
• The increasing prevalence of respiratory and metabolic disorders, aging populations, and technological advancements in ABG kits are driving the demand for arterial blood gas testing, particularly in critical care settings

Opportunity

“Integration of Smart Connectivity and Digital Platforms”

• The adoption of cloud-based diagnostics, EHR-integrated ABG analyzers, and smart barcode-enabled syringes is revolutionizing arterial blood gas testing
• These technologies allow for real-time data sharing, remote patient monitoring, and automated result interpretation, which improve clinician decision-making and reduce diagnostic delays
• There is also rising demand for portable ABG kits in ambulances, remote clinics, and field hospitals, particularly in underserved or rural settings

For instance,

• In March 2025, a U.S.-based medtech firm launched a wirelessly connected ABG analyzer that uploads patient results directly to a central hospital system, reducing manual transcription errors and enhancing traceability 
• The adoption of cloud-based diagnostics, EHR-integrated analyzers, and portable ABG kits is enhancing real-time data sharing, remote monitoring, and diagnostic accuracy, particularly in underserved areas

Restraint/Challenge

“High Cost and Limited Access in Developing Regions”

• The high cost of automated ABG analyzers, specialized syringes, and maintenance services creates a financial burden for small hospitals and diagnostic centers, particularly in low- and middle-income countries
• Limited reimbursement policies and lack of skilled personnel further hinder widespread adoption, resulting in inequitable access to critical diagnostics
• Infrastructural barriers such as lack of cold chain, poor inventory management, and under-equipped ICUs also affect the timely deployment of ABG kits in many regions

 For instance,

• According to a 2023 article in the Journal of Global Health, less than 30% of district hospitals in sub-Saharan Africa have access to reliable blood gas testing due to high setup and operational costs 
• High costs, limited reimbursement, lack of trained personnel, and infrastructural challenges are major barriers restricting access to arterial blood gas kits in low- and middle-income countries

Global Arterial Blood Gas Kits Market Scope

The market is segmented on the basis of product type, type, technology, application, needle gauge, syringe volume, end user and distribution channel.

Global Arterial Blood Gas Kits Market Regional Analysis

“North America is the Dominant Region in the Global Arterial Blood Gas Kits Market”

• North America holds the largest share of the global arterial blood gas kits market, attributed to its highly developed healthcare infrastructure, early adoption of advanced diagnostic technologies, and presence of major medical device manufacturers
• U.S. plays a key role, with increasing ICU admissions, high prevalence of respiratory disorders such as COPD and asthma, and a strong emphasis on point-of-care testing in emergency and critical care settings
• Robust reimbursement systems, strong government support for digital healthcare solutions, and ongoing innovation in ABG analyzer technology contribute to sustained market leadership
• Furthermore, the rise in demand for integrated, cloud-connected ABG systems across hospitals and diagnostic centers enhances operational efficiency and supports clinical decision-making, reinforcing market dominance

“Asia-Pacific is Projected to Register the Highest Growth Rate”

• Asia-Pacific is expected to experience the fastest growth in the arterial blood gas kits market, fuelled by improving healthcare infrastructure, growing investments in intensive care units, and a rising geriatric population
• Countries such as China, India, and Japan are emerging as high-potential markets due to increasing incidence of chronic respiratory and metabolic conditions requiring regular blood gas monitoring.
• Japan leads in adopting smart diagnostic solutions, while China and India are witnessing a surge in government and private sector funding aimed at improving ICU care and accessibility to point-of-care testing
• In addition, rising awareness about early diagnosis, expanding hospital networks, and the growing availability of portable ABG analysers in rural and urban areas are accelerating market expansion across the region

Global Arterial Blood Gas Kits Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• Thermo Fisher Scientific Inc. (U.S.)
• Abbott (U.S.)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Siemens Healthineers AG (Germany)
• Hamilton Company (U.S.)
• BD (U.S.)
• Radiometer Medical ApS (Denmark)
• Nova Biomedical (U.S.)
• Werfen, S.A. (Spain)
• Medica Corporation (U.S.)
• Sensa Core (India)
• EDAN Instruments, Inc. (China)
• Erba Diagnostics FZ-LLC (UAE)
• Techno MedicaCo., Ltd. (Japan)

Latest Developments in Global Arterial Blood Gas Kits Market

• In April 2022, Siemens Healthineers received U.S. FDA approval for its RAPIDPoint 500e Blood Gas Analyzer. This system is compatible with RAPIDLyte Arterial Sampling Syringes and Multicap Capillaries, strengthening Siemens' position in the ABG market 

SKU-73899